Effects of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate on phenytoin-induced embryopathy in mice

This publication has 13 references indexed in Scilit:

• Inhibition of trimethadione and dimethadione teratogenicity by the cyclooxygenase inhibitor acetylsalicylic acid: A unifying hypothesis for the teratologic effects of hydantoin anticonvulsants and structurally related compounds
  Toxicology and Applied Pharmacology, 1989
• Pharmacological studies on the potentiation of phenytoin teratogenicity by acetaminophen
  Teratology, 1986
• GENETIC PREDISPOSITION TO PHENYTOIN-INDUCED BIRTH DEFECTS
  The Lancet, 1985
• Short-Term Tests with Biochemical End Points Relevant to the Prediction of Carcinogenic Potential of Drugs
  Drug Metabolism Reviews, 1983
• Studies on 5,5-diphenylhydantoin irreversible binding to rat liver microsomal proteins
  Biochemical Pharmacology, 1982
• Teratogenicity of diphenylhydantoin in the New Zealand white rabbit
  Teratology, 1980
• Chemical-biological reactions common to teratogenesis and mutagenesis
  Environmental Health Perspectives, 1978
• Prostaglandins and skin tumor promotion: Inhibition of tumor promoter-induced ornithine decarboxylase activity in epidermis by inhibitors of prostaglandin synthesis
  Biochemical and Biophysical Research Communications, 1977
• The fetal hydantoin syndrome
  The Journal of Pediatrics, 1975
• Diphenylhydantoin teratogenicity in rats
  Toxicology and Applied Pharmacology, 1972